Finding 553863 (2022-008)

Material Weakness
Requirement
ABH
Questioned Costs
-
Year
2022
Accepted
2025-04-03
Audit: 352548
Organization: So Consortium (OH)

AI Summary

  • Core Issue: The Consortium lacked effective internal controls over Federal award expenditures, leading to potential non-compliance with Federal requirements.
  • Impacted Requirements: Proper approval from both the Director and Comptroller was not documented for a significant number of expenditures, raising concerns about compliance.
  • Recommended Follow-Up: Implement and enforce policies to ensure all invoices are reviewed and approved by the Director and Comptroller, with documentation on each invoice to confirm compliance.

Finding Text

The Consortium should have established and maintained effective internal control over Federal award expenditures to provide reasonable assurance that the Consortium was managing Federal awards in compliance with Federal statutes, regulations and the terms and conditions of the Federal award. These controls should have included proper approval / authorization of all outgoing payments being made by the fiscal agent on behalf of the Consortium. It appeared the procedure that was supposed to be in place was that both the Director and the Comptroller were to sign off on all invoices prior to payments being made. Due to the lack of controls over expenditures, during testing there was no indication on the invoice that the Director and Comptroller reviewed and approved the expenditures for nine out of seventeen expenditures tested for the WIOA Cluster. There was also no indication on the invoice that the Director and Comptroller reviewed and approved the expenditures for eleven out of seventeen expenditures tested for the National Emergency Grant. Policies and procedures should be established and implemented to verify that controls over federal expenditures to timely prevent or detect noncompliance are in place and operating effectively. Failure to do so increases the likelihood of unallowable expenditures and material non-compliance with program requirements going undetected. The Director and Comptroller should review and approve each invoice in order to determine that expenditures are in accordance with grant requirements and Federal laws and such approval should be documented on each invoice.

Categories

Allowable Costs / Cost Principles Internal Control / Segregation of Duties

Other Findings in this Audit

  • 553843 2022-004
    Material Weakness Repeat
  • 553844 2022-004
    Material Weakness Repeat
  • 553845 2022-004
    Material Weakness Repeat
  • 553846 2022-004
    Material Weakness Repeat
  • 553847 2022-004
    Material Weakness Repeat
  • 553848 2022-004
    Material Weakness Repeat
  • 553849 2022-005
    Material Weakness Repeat
  • 553850 2022-005
    Material Weakness Repeat
  • 553851 2022-005
    Material Weakness Repeat
  • 553852 2022-005
    Material Weakness Repeat
  • 553853 2022-005
    Material Weakness Repeat
  • 553854 2022-006
    Material Weakness Repeat
  • 553855 2022-007
    Material Weakness Repeat
  • 553856 2022-007
    Material Weakness Repeat
  • 553857 2022-007
    Material Weakness Repeat
  • 553858 2022-007
    Material Weakness Repeat
  • 553859 2022-007
    Material Weakness Repeat
  • 553860 2022-007
    Material Weakness Repeat
  • 553861 2022-008
    Material Weakness
  • 553862 2022-008
    Material Weakness
  • 553864 2022-008
    Material Weakness
  • 553865 2022-008
    Material Weakness
  • 553866 2022-008
    Material Weakness
  • 1130285 2022-004
    Material Weakness Repeat
  • 1130286 2022-004
    Material Weakness Repeat
  • 1130287 2022-004
    Material Weakness Repeat
  • 1130288 2022-004
    Material Weakness Repeat
  • 1130289 2022-004
    Material Weakness Repeat
  • 1130290 2022-004
    Material Weakness Repeat
  • 1130291 2022-005
    Material Weakness Repeat
  • 1130292 2022-005
    Material Weakness Repeat
  • 1130293 2022-005
    Material Weakness Repeat
  • 1130294 2022-005
    Material Weakness Repeat
  • 1130295 2022-005
    Material Weakness Repeat
  • 1130296 2022-006
    Material Weakness Repeat
  • 1130297 2022-007
    Material Weakness Repeat
  • 1130298 2022-007
    Material Weakness Repeat
  • 1130299 2022-007
    Material Weakness Repeat
  • 1130300 2022-007
    Material Weakness Repeat
  • 1130301 2022-007
    Material Weakness Repeat
  • 1130302 2022-007
    Material Weakness Repeat
  • 1130303 2022-008
    Material Weakness
  • 1130304 2022-008
    Material Weakness
  • 1130305 2022-008
    Material Weakness
  • 1130306 2022-008
    Material Weakness
  • 1130307 2022-008
    Material Weakness
  • 1130308 2022-008
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
17.258 Wia Adult Program $2.31M
17.277 Workforce Investment Act (wia) National Emergency Grants $1.22M
17.278 Wia Dislocated Worker Formula Grants $1.10M
17.259 Wia Youth Activities $477,315
93.788 Opioid Str $178,115
17.225 Unemployment Insurance $101,963
17.207 Employment Service/wagner-Peyser Funded Activities $9,589
17.245 Trade Adjustment Assistance $1,497